Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Minsheng Binjiang Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the development, manufacturing, and international export of high-quality finished dosage forms. As a subsidiary of the long-standing Minsheng Pharmaceutical Group, the company operates advanced manufacturing facilities that comply with US FDA, EU GMP, and Chinese GMP standards. Their product portfolio primarily features small molecule therapeutics, with a strong emphasis on gastrointestinal treatments, cardiovascular drugs, and corticosteroids. In addition to its own product line, the company serves as a significant Contract Development and Manufacturing Organization (CDMO) for global pharmaceutical partners seeking high-standard production in the Asian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Minsheng Binjiang Pharmaceutical.